Genetic predisposition to gastric cancer

QJM: An International Journal of Medicine

Volumn 92, Issue 1, 1999, Pages 5-10

  Bevan, S ^a   Houlston, R S ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PEPSINOGEN; TUMOR MARKER; UVOMORULIN;

CARCINOGENESIS; CHROMOSOME MAP; DISEASE CLASSIFICATION; GENE MUTATION; GENETIC EPIDEMIOLOGY; GENETIC PREDISPOSITION; GENETIC RISK; HUMAN; POPULATION; PRIORITY JOURNAL; REVIEW; SCREENING; STOMACH CANCER;

EID: 0032927269     PISSN: 00335622     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/92.1.5     Document Type: Review

References (62)

1. Cancer incidence in five continents. IARC Press, 1996.
2. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal type carcinoma. An attempt at a histoloclinical classification. Acta Patholica Microbiologica Scand 1965; 64:31-49.
3. Lo SS, Wu CW, Hsieh MC, Kuo HS, Lui WY, P'Eng FK. Relationship between age and clinical characteristics of patients with gastric cancer. J Gastroenterol Hepatol 1996; 6:511-14.
4. Bartsch H, Pignatelli B, Calmels S, Ohshima H. Inhibition of nitrosation. Basic Life Sci 1993; 61:27-44.
5. Haenszel W, Correa P, Lopez A, Cuello C, Zarama G, Zavala D, Fontham E. Serum micro-nutrient levels in relation to gastric pathology. Int J Cancer 1985; 36:43-8.
6. Kuipers EJ. H. pylori and the risk and management of associated diseases: gastritis, ulcer disease, atrophic gastritis and gastric cancer. Aliment Pharmacol Ther 1997; Suppl. 1:71-88.
7. Woolf CM. Investigations on genetic aspects of carcinoma of the stomach and breast. Univ Calif Publ Health 1954; 2:265-350.
8. Videbaek A, Mosbech J. The aetiology of gastric carcinoma elucidated by a study of 302 pedigrees. Acta Med Scand 1954; 149:137-59.
9. Macklin MT. Inheritance of cancer of the stomach and large intestine in man. J Nat Cancer Inst 1960; 24:551-71.
10. Zanghieri G, Di Gregorio C, Sacchetti C, Fante R, Sassatelli R, Cannizzo G, Carriero A, Ponz de Leon M. Familial occurrence of gastric cancer in the 2-year experience of a population-based registry. Cancer 1990; 66:2047-51.
11. La Vecchia C, Negri E, Franceschi S, Gentile A. Family history and the risk of stomach and colorectal cancer. Cancer 1992; 70:50-5.
12. Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 1994; 86:1600-8.
13. Nagase H, Ogino K, Yoshida I, Matsuda H, Yoshida M, Nakamura H, Dar S, Ishimaru M. Family history-related risk of gastric cancer in Japan: a hospital-based case-control study. Jpn J Cancer Res 1996; 87:1025-8.
14. Hoshino H, Hirayama T, Arimoto H, Maruyama K, Kitaoka H, Yamada T, Hirota T, Watanabe S, Tanaka M, Suzuki S, et al. Gastric cancer risk factors: a case-control study based on medical records. Jpn J Cancer Res 1985; 76:846-50.
15. Palli D, Galli M, Caporaso NE, Cipriani F, Decarli A, Saieva C, Fraumeni JF Jr, Buiatti E. Family history and risk of stomach cancer in Italy. Cancer Epidemiol Biomarkers Prev 1994; 3:15-18.
16. Karner-Hanusch J, Mittlbock M, Fillipitsch T, Herbst F. Family history as a marker of risk for colorectal cancer: Austrian experience. World J Surg 1997; 21:205-9.
17. Sokoloff B. Predisposition to cancer in the Bonaparte family. Am J Surg 1938; 40:673-8.
18. Munoz SE, Ferraroni M, La-Vecchia C, Decarli A. Gastric cancer risk factors in subjects with family history. Cancer Epidemiol Biomarkers Prev 1997; 6:137-40.
19. La-Vecchia C, Ferraroni M, D'Avanzo B, Franceschi S, Decarli A, Baron JA. Number of siblings and subsequent gastric cancer risk. Eur J Cancer Prev 1995; 4:69-72.
20. Parsonnet J, Friedman GD, Orentreich N, Vogelman H. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 1997; 40:297-301.
21. Kuipers EJ, Klinkenberg-Knol EC, Vandenbroucke-Grauls CM, Appelmelk BJ, Schenk BE, Meuwissen SG. Role of H. Pylori in the pathogenesis of atrophic gastritis. Scand J Gastroenterol Suppl 1997; 223:28-34.
22. Kuipers EJ, Appelmelk BJ. H. pylori and atrophic gastritis. Biomed Pharmacother 1997; 51(4):150-5.
23. Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P, Taite H, Scoular R, Miller A, Reeve AE. E-cadherin germline mutations in familial gastric cancer. Nature 1998; 392:402-5.
24. Lynch HT, Smyrk T. Hereditary non-polyposis colorectal cancer (Lynch syndrome). An updated review. Cancer 1996; 78:1149-67.
25. Watson P, Lynch HT. Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer 1993; 71:677-85.
26. Sharma AK, Sharma SS, Mathur P. Familial juvenile polyposis with adenomatous-carcinomatous change. J Gastroenterol Hepatol 1995; 10:131-4.
27. Hizawa K, Iida M, Matsumoto T, Kohrogi N, Suekane H, Yao T, Fujishima M. Gastrointestinal manifestations of Cowden's disease. Report of four cases. J Clin Gastroenterol 1994; 18(1):13-18.
28. Williams CB, Goldblatt M, Delaney PV. Top and tail endoscopy and follow-up in Peutz-Jeghers syndrome. Endoscopy 1982; 14(3):82-4.
29. Ushio K, Sasagawa M, Doi H, Yamada T, Ichikawa H, Hojo K, Koyama Y, Sano R. Lesions associated with familial polyposis coli: studies of lesions of lesions of the stomach, duodenum, bones, and teeth. Gastrointest Radiol 1976; 1:67-80.
30. Burki N, Gencik A, Torhorst JK, Weber W, Muller H. Familial and histological analyses of 138 breast cancer patients. Breast Cancer Res Treat 1987; 10:159-67.
31. Narita T, Dobashi Y, Nakamura T, Yokoyama S, Matsuda K. Familial aggregation of soft tissue sarcomas: a report of three cases from a Li-Fraumeni like family. Arch Pathol Lab Med 1997; 121:493-8.
32. Birch JM. The Li-Fraumeni cancer family syndrome. J Pathol 1990; 161:1-2.
33. Haerer AF, Jackson JF, Evers CG. Ataxia Telangiectasia with gastric adenocarcinoma. JAMA 1969; 210:1884-7.
34. Branco I, da-Costa FB, Rodrigues A, Pires FR, Portugal MA, Goncalves MD. Gastric neoplasm associated with IgA deficiency. Importance of multidisciplinary care. Acta Med Port 1993; 12:587-92.
35. Nilssen DE, Brandtzaeg P, Froland SS, Fausa O. Subclass composition and J-chain expression of the 'compensatory' gastrointestinal IgG cell population in selective IgA deficiency. Clin Exp Immunol 1992; 87:237-45.
36. Ilyas M, Tomlinson IPM. The interactions of APC, E-cadherin and β-catenin in tumour development and progression. J Pathol 1997; 182:128-37.
37. Tamura G, Sakata K, Nishizuka S, Maesawa C, Suzuki Y, Iwaya T, Terashima M, Saito K, Satodate R. Inactivation of the E-cadherin gene in primary gastric carcinomas and gastric carcinoma cell lines. Jpn J Cancer Res 1996; 87:1153-9.
38. Renault B, Calistri D, Buonsanti G, Nanni O, Amadori D, Ranzani GN. Microsatellite instability and mutations of p53 and TGF-heta RII genes in gastric cancer. Hum Genet 1996; 98:601-7.
39. Keller G, Grimm V, Vogelsang H, Bischoff P. Mueller J, Siewert JR, Hofler H. Analysis for microsatellite instability and mutations of the DNA mismatch repair gene hMLH1 in familial gastric cancer. Int J Cancer 1996; 68:571-6.
40. Hsieh LL, Huang YC. Loss of heterozygosity of APC/MCC gene in differentiated and undifferentiated gastric carcinomas in Taiwan. Cancer Lett 1995; 96:169-74.
41. McKie AB, Filipe MI, Lemoine NR. Abnormalities affecting the APC and MCC tumour suppressor gene loci on chromosome 5q occur frequently in gastric cancer but not in pancreatic cancer. Int J Cancer 1993; 55:598-603.
42. Nelen MR, Van-Stavenen WC, Peeters EA, Hassel MB, Gorlin RJ, Hamm H, Lindboe CF, Fryns JP, Sijmons RH, Woods DG, Mariman EC, Padberg GW, Kremer H. Germline mutations in the PTEN/MMAC1 gene in patients with Cowdens disease. Hum Mol Genet 1997; 6:1383-7.
43. Jenne DE, Reimann H, Nezu J, Friedel W, Loff S, Jeschke R, Muller O, Back W, Zimmer M. Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet 1998; 18(1):38-43.
44. Moll UM, Schramm LM. p53 - an acrobat in tumourogenesis. Crit Rev Oral Biol Med 1998; 9(1):23-37.
45. Neuman WL, Wasylyshyn ML, Jacoby R, Erroi F, Angriman I, Montag A, Brasitus T, Michelassi F, Westbrook CA. Evidence for a common molecular pathogenesis in colorectal, gastric, and pancreatic cancer. Genes Chromosomes Cancer 1996; 3:468-73.
46. Ezaki T, Yanagisawa A, Ohta K, Aiso S, Watanabe M, Hibi T, Kato Y, Nakajima T, Ariyama T, Inazawa J, Nakamura Y, Horii A. Deletion mapping on chromosome 1p in well-differentiated gastric cancer. Br J Cancer 1996; 73:424-8.
47. Baffa R, Negrini M, Mandes B, Rugge M, Ranzani GN, Hirohashi S, Croce CM. Loss of heterozygosity for chromosome 11 in adenocarcinoma of the stomach. Cancer Res 1996; 56:268-72.
48. Emi M, Fujiwara Y, Nakajima T, Tsuchiya E, Tsuda H, Hirohashi S, Maeda Y, Tsuruta K, Miyaki M, Nakamura Y. Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer, and lung cancer. Cancer Res 1992; 52:5368-72.
49. Motomura K, Nishisho I, Takai S, Tateishi H, Okazaki M, Yamamoto M, Miki T, Honjo T, Mori T. Loss of alleles at loci on chromosome 13 in human primary gastric cancers. Genomics 1988; 2:180-4.
50. Kim CJ, Kim WH, Kim CW, Lee JB, Lee CK, Kim YL. Detection of 17p loss in gastric carcinoma using polymerase chain reaction. Lab Invest 1995; 72:232-6.
51. Vogel F, Motulsky AV. Human Genetics, 2nd edn. New York, Springer, 1986.
52. Torrado J, Ruiz B, Garay J, Cosme A, Arenas JI, Bravo JC, Fontham E, Correa P. Lewis, secretor, and ABO phenotypes, and sulfomucin expression in gastric intestinal metaplasia. Cancer Epidemiol Biomarkers Prev 1997; 6:287-9.
53. Elsborg L, Mosbech J. Pernicious anaemia as a risk factor in gastric cancer. Acta Med Scand 1979; 206:315-8.
54. Varis O, Valle J, Siurala M. Is Helicobacter pylori involved in the pathogenesis of the gastritis characteristic of pernicious anaemia? Comparison between pernicious anaemia relatives and duodenal ulcer relatives. Scand J Gastroenterol 1993; 28:705-8.
55. Thomsen M, Jorgensen F, Brandsborg M, Gimsing P, Nielsen JL, Ryder LP, Svejgaard A. Association of pernicious anaemia and intrinsic factor antibody with HLA-D. Tissue Antigens 1981; 17:97-103.
56. Humbert P, Dupond JL, Mallet H, Leconte de Floris R. Biermer's anemia, Hashimoto's thyroiditis, myasthenia and malignant thyoma. HLA b8, DR3 and DR5 antigens. Presse Med 1984; 13:439.
57. Hong JY, Yang CS. Genetic polymorphism of cytochrome p450 as a biomarker of susceptibility to environmental toxicity. Environ Health Perspect 1997; 105 Suppl 4:759-62.
58. Kato S, Onda M, Matsukura N, Tokunaga A, Matsuda N, Yamashita K, Shields PG. Genetic polymorphisms of the cancer related gene and H. pylori infection in Japanese gastric cancer patients. An age and gender matched case control study. Cancer 1996; 77(8 Suppl):1654-61.
59. Miki K, Ichinose M, Ishikawa KB, Yahagi N, Matsushima M, Kakei N, Tsukada S, Kido M, Ishihama S, Shimizu Y, et al. Clinical application of serum pepsinogen I and II levels for mass screening to detect gastric cancer. Jpn J Cancer Res 1993; 84:1086-90.
60. Miki K, Ichinose M, Kawamura N, Matsushima M, Ahmad HB, Kimura M, Sano J, Tashiro T, Kakei N, Oka H, et al. The significance of low serum pepsinogen levels to detect stomach cancer associated with extensive chronic gastritis in Japanese subjects. Jpn J Cancer Res 1989; 80:111-4.
61. Aoki K, Misumi J, Kimura T, Zhao W, Xie T. Evaluation of cutoff levels for screening of gastric cancer using serum pepsinogens and distributions of levels of serum pepsinogen I, II, and of PG I/PG II ratios in a gastric cancer case-control study. J Epidemiol 1997; 7:143-51.
62. Yamagata Z, Zhang Y, Shinozaki S. Influence of pepsinogen gene polymorphisms on serum pepsinogen. Ann Hum Genet 1997; 61:93-7.